MICHAEL SULEWSKI: Open Payments
NPI 1477981074 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 11 payments from 8 companies in 2025. Trend: 2023 $38 · 2024 $75 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $144 |
| Novo Nordisk Inc | 3 | $65 |
| ViiV Healthcare Company | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
| PFIZER INC. | 1 | $16 |
Products named: Yeztugo, CABENUVA, PIFELTRO, KEVEYIS, AIRSUPRA, Wegovy, Cologuard Collection Kit, Ozempic.
Industry payments across NC — which companies pay providers there.
